Search by Drug Name or NDC
NDC 45802-0169-72 alogliptin and metformin hydrochloride 12.5; 500 mg/1; mg/1 Details
alogliptin and metformin hydrochloride 12.5; 500 mg/1; mg/1
alogliptin and metformin hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE.
Product Information
| NDC | 45802-0169 |
|---|---|
| Product ID | 45802-169_8b580d35-0095-4c68-94d0-afc3c4be4f22 |
| Associated GPIs | 27992502100320 |
| GCN Sequence Number | 070526 |
| GCN Sequence Number Description | alogliptin benz/metformin HCl TABLET 12.5-500MG ORAL |
| HIC3 | C4F |
| HIC3 Description | ANTIHYPERGLYCEMIC,DPP-4 INHIBITOR-BIGUANIDE COMBS. |
| GCN | 34087 |
| HICL Sequence Number | 039970 |
| HICL Sequence Number Description | ALOGLIPTIN BENZOATE/METFORMIN HCL |
| Brand/Generic | Generic |
| Proprietary Name | alogliptin and metformin hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | alogliptin and metformin hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 500 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Pharmaceutical Class | Biguanide [EPC], Biguanides [CS], Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA203414 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 45802-0169-72 (45802016972)
| NDC Package Code | 45802-169-72 |
|---|---|
| Billing NDC | 45802016972 |
| Package | 60 TABLET, FILM COATED in 1 BOTTLE (45802-169-72) |
| Marketing Start Date | 2016-04-08 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.99967 |
| Pricing Unit | EA |
| Effective Date | 2024-01-17 |
| NDC Description | ALOGLIPTIN-METFORMIN 12.5-500 |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis